Irene A Malaty

Irene A Malaty MD

Associate Professor

Department: MD-NEUROLOGY-MOVEMENT DISORDER
Business Phone: (352) 273-5550

About Irene A Malaty

Dr. Malaty completed medical school at Indiana University School of Medicine before completing neurology residency and movement disorders fellowship at the University of Florida. She devotes her practice to clinical care, research, and education across the movement disorders spectrum. She specializes in the care of Parkinson disease (PD) and is director of a Parkinson Foundation Center of Excellence at UF. She also specializes in Tourette syndrome (TS) in patients of all ages and is director of the Tourette Association of America Center of Excellence at UF. Additionally, she has an active botulinum toxin injection practice treating diverse neurological disorders. Across these key components of her specialty, she takes time to care for individuals with complex motor and non-motor symptoms in a comprehensive manner.

Dr. Malaty has been awarded several teaching awards including University of Florida College of Medicine Exemplary Teacher award and the Clinical Educator of the Year award. She has also been recognized for her expert clinical care with a University of Florida College of Medicine Clinical Outpatient Excellence Award. She has enjoyed lecturing nationally and internationally.

Dr. Malaty is a primary investigator in a number of trials in movement disorders and helps direct the movement disorder trials at UF. As an example, she is leading research at UF to investigate outcomes of varied care in Parkinson patients as part of an international collaboration. She has authored multiple publications and chapters in movement disorders.

In 2017, Dr. Malaty became the first female president of the Florida Society of Neurology, on the 50th anniversary of that organization. She aspires to advocate for improved care and education in neurological disorders through this role and in her national position on the movement disorders subsection of the American Academy of Neurology (AAN). She was selected for the inaugural class of the prestigious Women Leading in Neurology program of the AAN and will continue to devote time and effort to improving the lives of individuals living with neurological disorders.

Honors & Awards

UF College of Medicine Clinical Outpatient Excellence Award
2017 · University of Florida
Customer Service Key Award
2017 · University of Florida
UF College of Medicine Exemplary Teacher Award
2016 · University of Florida
Customer Service Key Award
2014 · University of Florida
UF College of Medicine Exemplary Teacher Award
2013 · University of Florida
Clinical Educator of the Year Award
2012 · University of Florida

Clinical Profile

Specialties
  • Neurology
Areas of Interest
  • Basal ganglia dysfunction
  • Chronic motor tic disorder
  • Deep brain stimulation
  • Dystonia
  • Essential tremor
  • Movement – uncontrollable
  • Movement – uncontrolled or slow
  • Movement – uncoordinated
  • Movement – unpredictable or jerky
  • Obsessive-compulsive disorder
  • Parkinson disease
  • Progressive supranuclear palsy
  • Tourette syndrome
  • Tremor

Publications

2019 Journal of Developmental and Behavioral Pediatrics
2018 Movement Disorders Clinical Practice
2017 Journal of Neurology Neurosurgery and Psychiatry
2015 Journal of Clinical and Experimental Neuropsychology
2014 Archives of Physical Medicine and Rehabilitation
2014 Current Neurology and Neuroscience Reports
2013 American Family Physician
2011 Parkinsonism & Related Disorders
2011 Journal of the International Neuropsychological Society
2010 Journal of Neurosurgery-Spine
2010 Parkinsonism & Related Disorders
2010 Parkinsonism & Related Disorders
2009 Journal of Neurology Neurosurgery and Psychiatry

Grants

December 2018 – August 2019
Southeast Area Centers of Excellence 2019
TOURETTE ASSOCIATION OF AMERICA · Principal Investigator
July 2018ACTIVE
Parkinson Foundation Center of Excellence 2018-2019
PARKINSONS FOU · Principal Investigator
April 2018 – August 2018
SE Regional Centers of Excellence Community Outreach & Education Advocacy Program
TOURETTE ASSOCIATION OF AMERICA · Principal Investigator
June 2017 – June 2018
Parkinson Foundation Center of Excellence
NATL PARKINSON FOU · Principal Investigator
August 2016ACTIVE
Scaling and Sequencing Motor Output in Humans: fMRI Study
NATL INST OF HLTH NINDS ·
July 2016 – June 2017
National Parkinson Foundation (NPF) Center of Excellence
NATL PARKINSON FOU · Principal Investigator
July 2016ACTIVE
The Human Thalamocortical Network in tourette syndrome
NATL INST OF HLTH NINDS ·
February 2016 – February 2019
Prevalence of TD and tics among a community-recruited sa
TOURETTE ASSOCIATION OF AMERICA · Project Manager
October 2015 – October 2018
a phase 3 multicenter randomized double blind
INVENTIV HEALTH CLINICAL LLC · Principal Investigator
September 2015ACTIVE
Dystonia Coalition Projects
DYSTONIA MEDICAL RES FOU · Principal Investigator
July 2015 – June 2017
Center of Excellence 2015-2016
NATL PARKINSON FOU · Principal Investigator
November 2014 – November 2017
Amaryllis
INVENTIV HEALTH CLINICAL LLC · Principal Investigator
November 2014 – October 2018
TSA CoE
TOURETTE ASSOCIATION OF AMERICA · Principal Investigator
September 2014 – September 2017
OPEN-LABEL SAFETY STUDY OF ADS-5102 (AMANTADINE HCL) EXTENDED RELEASE CAPSULES FOR THE TREATMENT OF LEVODOPA INDUCED DYSKINESIA
ADAMAS PHARMACEUTICALS · Principal Investigator
August 2014 – August 2017
EASE LID
ADAMAS PHARMACEUTICALS · Principal Investigator
August 2014 – August 2017
Auspex TS
AUSPEX PHARMACEUTICALS · Principal Investigator
December 2013 – March 2016
MOVE-PD
RHYTHM PHARMACEUTICALS · Principal Investigator
July 2013 – December 2017
A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF SD-809 EXTENDED RELEASE FOR THE TREATMENT OF CHOREA ASSOCIATED WITH HUNTINGTON DISEASE
AUSPEX PHARMACEUTICALS · Principal Investigator
May 2013 – December 2016
M12-920 Duodopa Non-Motor Symptoms
ABBVIE · Principal Investigator
June 2012 – June 2018
CD FLEX
MERZ PHARMACEUTICALS GMBH · Principal Investigator
June 2010 – June 2019
Quality Improvement Initiative (QII) Phase II
PARKINSONS FOU · Principal Investigator
November 2009 – September 2017
Duodopa 005
IQVIA · Principal Investigator